Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter

K-Number: K232651 · 2023-09-29

Decision Date2023-09-29
Product CodeDRF
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter is a medical device manufactured by Boston Scientific Corporation. It received FDA 510(k) clearance on 2023-09-29 under approval number K232651. The device is classified under product code DRF. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter?

BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter is a medical device that received FDA 510(k) clearance on 2023-09-29. It is manufactured by Boston Scientific Corporation. The 510(k) number is K232651.

When was BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter approved by the FDA?

BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter received FDA 510(k) clearance on 2023-09-29, under approval number K232651.

What company makes BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter?

BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter is manufactured by Boston Scientific Corporation.

What is the FDA product code for BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter?

The FDA product code for BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter is DRF.

Related Clinical Trials

Other Devices by Boston Scientific Corporation

View all 176 devices →

Related Devices (Code: DRF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.